Statement Of Comprehensive Income [Abstract]

ABIVAX - Filing #5984181

Concept	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31
Statement of comprehensive income [abstract]
Profit (loss)	176 242 EUR	— EUR	176 242 EUR	— EUR	— EUR	— EUR	176 242 EUR	147 740 EUR	147 740 EUR	— EUR	147 740 EUR	— EUR	— EUR	— EUR	— EUR	60 740 EUR	— EUR	60 740 EUR	—	— EUR	— EUR
Other comprehensive income [abstract]
Other comprehensive income	— EUR	31,000 EUR	—	— EUR	— EUR	187,000 EUR	219,000 EUR	225,000 EUR	— EUR	112,000 EUR	225,000 EUR	— EUR	112,000 EUR	— EUR	— EUR	235,000 EUR	235,000 EUR	— EUR	235,000 EUR	— EUR	— EUR
Comprehensive income	176 242 EUR	31,000 EUR	—	— EUR	— EUR	187,000 EUR	176 461 EUR	147 516 EUR	147 740 EUR	112,000 EUR	—	— EUR	112,000 EUR	— EUR	— EUR	60 506 EUR	235,000 EUR	60 740 EUR	—	— EUR	— EUR